Identification of a human anti-CD55 single-chain Fv by subtractive panning of a phage library using tumor and nontumor cell lines

Cancer Research

Volumn 59, Issue 11, 1999, Pages 2718-2723

  Ridgway, John B B ^c   Ng, Eric ^a,c   Kern, Jeffrey A ^b,c   Lee, James ^c   Brush, Jennifer ^c   Goddard, Audrey ^c   Carter, Paul ^c  

^a RUSH MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DECAY ACCELERATING FACTOR;

ANTIGEN BINDING; ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; CROSS REACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; PRIORITY JOURNAL;

ANTIGENS, CD55; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; CELL LINE; CROSS REACTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; IMMUNOGLOBULIN VARIABLE REGION; TUMOR CELLS, CULTURED;

EID: 0033153570     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Riethmüller, G., Schneider-Gädicke, E., Schlimok, G., Schmiegel, W., Raab, R., Höffken, K., Gruber, R., Pichlmaier, H., Hirche, H., Pichlmayr, R., Buggisch, P., Witte, J., and the German Cancer Aid 17-1A Study Group. Randomized trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. Lancet, 343: 1177-1183, 1994.
2. Riethmüller, G., Holz, E., Schlimok, G., Schmiegel, W., Raab, R., Höffken, K., Gruber, R., Funke, I., Pichlmaier, H., Hirche, H., Buggisch, P., Witte, J., and Pichlmayr, R. Monoclonal antibody therapy for resected Dukes' C colorectal cancer: seven-year outcome of a multicenter randomized trial. J. Clin. Oncol., 16: 1788-1794, 1998.
3. Maloney, D. G., Grillo-López, A. J., White, C. A., Bodkin, D., Schilder, R. J., Neidhart, J. A., Janakiraman, N., Foon, K. A., Liles, T. M., Dallaire, B. K., Wey, K., Royston, I., Davis, T., and Levy, R. IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma. Blood, 90: 2188-2195, 1997.
4. McLaughlin, P., Grillo-López, A. J., Link, B. K., Levy, R., Czuczman, M. S., Williams, M. E., Heyman, M. R., Bence-Bruckler, I., White, C. A., Cabanillas, F., Jain, V., Ho, A. D., Lister, J., Wey, K., Shen, D., and Dallaire, B. K. Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program. J. Clin. Oncol., 16: 2825-2833, 1998.
5. HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer. J. Clin. Oncol., 14: 697-699, 1996.
6. Press, O. W., Eary, J. F., Appelbaum, F. R., Martin, P. J., Badger, C. C., Nelp, W. B., Glenn, S., Butchko, G., Fisher, D., Porter, B., Matthews, D. C., Fisher, L. D., and Bernstein, I. D. Radiolabeled-antibody therapy of B-cell lymphoma with autologous bone marrow support. N. Engl. J. Med., 329: 1219-1224, 1993.
7. 131I-B1 (anti-CD20) antibody therapy with autologous stem cell transplantation for relapsed B cell lymphomas. Lancet, 346: 336-340, 1995.
8. 131I]anti-B1 (anti-CD20) antibody. N. Engl. J. Med., 329: 459-465, 1993.
9. Kaminski, M. S., Zasadny, K. R., Francis, I. R., Fenner, M. C., Ross, C. W., Milik, A. W., Estes, J., Tuck, M., Regan, D., Fisher, S., Glenn, S. D., and Wahl, R. L. Iodine-131-anti-B1 radioimmunotherapy for B-cell lymphoma. J. Clin. Oncol., 14: 1974-1981, 1996.
10. Reff, M. E., Carner, K., Chambers, K. S., Chinn, P. C., Leonard, J. E., Raab, R., Newman, R. A., Hanna, N., and Anderson, D. R. Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20. Blood, 83: 435-445, 1994.
11. HER2 antibody for human cancer therapy. Proc. Natl. Acad. Sci. USA, 89: 4285-4289, 1992.
12. McCafferty, J., Griffiths, A. D., Winter, G., and Chiswell, D. J. Phage antibodies: filamentous phage displaying antibody variable domains. Nature (Lond.), 348: 552-554, 1990.
13. Griffiths, A. D., Williams, S. C., Hartley, O., Tomlinson, I. M., Waterhouse, P., Crosby, W. L., Kontermann, R., Jones, P. T., Low, N. M., Allison, T. J., Prospero, T. D., Hoogenboom, H. R., Nissim, A., Cox, J. P. L., Harrison, J. L., Zaccolo, M., Gherardi, E., and Winter, G. Isolation of high affinity human antibodies directly from large synthetic repertoires. EMBO J., 13: 3245-3260, 1994.
14. Vaughan, T. J., Williams, A. J., Pritchard, K., Osbourn, J. K., Pope, A. R., Earnshaw, J. C., McCafferty, J., Hodits, R. A., Wilton, J., and Johnson, K. S. Human antibodies with sub-nanomolar affinities isolated from a large non-immunized phage display library. Nat. Biotechnol., 14: 309-314, 1996.
15. Sheets, M. D., Amersdorfer, P., Finnem, R., Sargent, P., Lindqvist, E., Schier, R., Hemingsen, G., Wong, C., Gerhart, J. C., and Marks, J. D. Efficient construction of a large nonimmune phage antibody library: the production of high-affinity human single-chain antibodies to protein antigens. Proc. Natl. Acad. Sci. USA, 95: 6157-6162, 1998.
16. Nissim, A., Hoogenboom, H. R., Tomlinson, I. M., Flynn, G., Midgley, C., Lane, D., and Winter, G. Antibody fragments from a "single pot" phage. EMBO J., 13: 692-698, 1994.
17. Marks, J. D., Ouwehand, W. H., Bye, J. M., Finnem, R., Gorick, B. D., Voak, D., Thorpe, S. J., Hughes-Jones, N. C., and Winter, G. Human antibody fragments specific for human blood group antigens from a phage display library. Bio/Technology, 11: 1145-1149, 1992.
18. Portolano, S., McLachlan, S. M., and Rapoport, B. High affinity, thyroid-specific human autoantibodies displayed on the surface of filamentous phage use V genes similar to other autoantibodies. J. Immunol., 151: 2839-2851, 1993.
19. de Kruif, J., Terstappen, L., Boel, E., and Logtenberg, T. Rapid selection of cell subpopulation-specific human monoclonal antibodies from a synthetic phage antibody library. Proc. Natl. Acad. Sci. USA. 92: 3938-3942, 1995.
20. Van Ewijk, W., de Kruif, J., Germeraad, W. T., Berendes, P., Ropke, C., Platenburg, P. P., and Logtenberg, T. Subtractive isolation of phage-displayed single-chain antibodies to thymic stromal cells by using intact thymic fragments. Proc. Natl. Acad. Sci. USA, 94: 3903-3908, 1997.
21. Cai, X., and Garen, A. Anti-melanoma antibodies from melanoma patients immunized with genetically modified autologous tumor cells: selection of specific antibodies from single-chain Fv fusion phage libraries. Proc. Natl. Acad. Sci. USA, 92: 6537-6541, 1995.
22. H antibody cloned from a fusion phage library of a vaccinated melanoma patient. Proc. Natl. Acad. Sci. USA, 93: 6280-6285, 1996.
23. H or single-chain Fv antibody fragments derived from the antibody repertoire of a vaccinated melanoma patient as a source of melanoma-specific targeting molecules. Proc. Natl. Acad. Sci. USA, 94: 9261-9266, 1997.
24. Marks, J. D., Hoogenboom, H. R., Bonnert, T. P., McCafferty, J., Griffiths, A. D., and Winter, G. By-passing immunization. Human antibodies from V-gene libraries displayed on phage. J. Mol. Biol., 222: 581-597, 1991.
25. Christensen, J., and Leslie, R. G. Q. Quantitative measurement of Fc receptor activity on human peripheral blood monocytes and the monocyte-like cell line, U937, by laser flow cytometry. J. Immunol. Methods, 132: 211-219, 1990.
26. Atwell, S., Ridgway, J. B. B., Wells, J. A., and Carter, P. Stable heterodimers from remodeling the domain interface of a homodimer using a phage display library. J. Mol. Biol., 270: 26-35, 1997.
27. Carter, P., Kelley, R. F., Rodrigues, M. L., Snedecor, B., Covarrubias, M., Velligan, M. D., Wong, W. L. T., Rowland, A. M., Kotts, C. E., Carver, M. E., Yang, M., Bourell, J. H., Shepard, H. M., and Henner, D. High level Escherichia coli expression and production of a bivalent humanized antibody fragment. Biotechnology, 10: 163-167, 1992.
28. Chirgwin, J. M., Przybyla, A. E., MacDonald, R. J., and Rutter W. J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry, 18: 5294-5299, 1979.
29. Aviv, H., and Leder, P. Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose. Proc. Natl. Acad. Sci. USA, 69: 1408-1412, 1972.
30. Suva, L. J., Winslow, G. A., Wettenhall, R. E., Hammonds, R. G., Moseley, J. M., Diefenbach-Jagger, H., Rodda, C. P., Kemp, B. E., Rodriguez, H., Chen, E. Y., Hudson, P. J., Martin, T. J., and Wood, W. I. A parathyroid hormone-related protein implicated in malignant hypercalcemia: cloning and expression. Science (Washington DC), 237: 893-896, 1987.
31. Seed, B., and Aruffo, A. Molecular cloning of the CD2 antigen, the T-cell erythrocyte receptor, by a rapid immunoselection procedure. Proc. Natl. Acad. Sci. USA, 84: 3365-3369, 1987.
32. Merchant, A. M., Zhu, Z., Yuan, J. Q., Goddard, A., Adams, C. W., Presta, L. G., and Carter, P. An efficient route to human bispecific IgG. Nat. Biotechnol., 16: 677-681, 1998.
33. Tzahar, E., and Yarden, Y. The ErbB-2/HER2 oncogenic receptor of adenocarcinomas: from orphanhood to multiple stromal ligands. Biochim. Biophys. Acta, 1377: M25-M37, 1998.
34. Voldborg, B. R., Damstrup, L., Spang-Thomsen, M., and Poulsen, H. S. Epidermal growth factor receptor (EGFR) and EGFR mutations, function and possible role in clinical trials. Ann. Oncol., 8: 1197-1206, 1997.
35. Nicholson-Weller, A., and Wang, C. E. Structure and function of decay-accelerating factor. J. Lab. Clin. Med., 123: 485-491, 1994.
36. Cheung, N-K. V., Walter, E. I., Smith-Mensah, W. H., Ratnoff, W. D., Tykocinski, M. L., and Medof, M. E. Decay-accelerating factor protects human tumor cells from complement-mediated cytotoxicity in vitro. J. Clin. Invest., 81: 1122-1128, 1988.
37. Niehans, G. A., Cherwitz, D. L., Staley, N. A., Knapp, D. J., and Dalmasso, A. P. Human carcinomas variably express the complement inhibitory proteins CD46 (membrane cofactor protein), CD55 (decay-accelerating factor), and CD59 (protectin). Am. J. Pathol., 149: 129-142, 1996.
38. Barratt-Boyes, S. M. Making the most of mucin: a novel target for tumor immunotherapy. Cancer Immunol. Immunother., 43: 142-151, 1996.
39. Couto, J. R., Blank, E. W., Peterson, J. A., Kiwan, R., Padlan, E. A., and Ceriani, R. L. Engineering of antibodies for breast cancer therapy: construction of chimeric and humanized versions of the murine monoclonal antibody BrE-3. Adv. Exp. Med. Biol., 353: 55-59, 1994.
40. Couto, J. R., Padlan, E. A., Blank, E. W., Peterson, J. A., and Ceriani, R. L. Humanization of KC4G3, an anti-human carcinoma antibody. Hybridoma, 13: 215-219, 1994.
41. Baker, T. S., Bose, C. C., Caskey-Finney, H. M., King, D. J., Lawson, A. D., Lyons, A., Mountain, A., Owens, R. J., Rolfe, M. R., Sehdev, M., Yarranton, G. T., and Adair, J. R. Humanization of an anti-mucin antibody for breast and ovarian cancer therapy. Adv. Exp. Med. Biol., 353: 61-82, 1994.
42. Henderikx, P., Kandilogiannaki, M., Petrarca, C., von Mensdorff-Pouilly, S., Hilgers, J. H. M., Krambovitis, E., Arends, J. W., and Hoogenboom, H. R. Human single-chain Fv antibodies to MUC1 core peptide selected from phage display libraries recognizes unique epitopes and predominantly bind adenocarcinoma. Cancer Res., 58: 4324-4332, 1998.
43. Liang, P., and Pardee, A. B. Recent advances in differential display. Curr. Opin. Immunol. 7: 274-280, 1995.
44. Schena, M., Shalon, D., Davis, R. W., Brown, P. O. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science (Washington DC), 270: 467-470, 1995.
45. DeRisi, J., Penland, L., Brown, P. O., Bittner, M. L., Meltzer, P. S., Ray, M., Chen, Y., Su, Y. A., and Trent, J. M. Use of a cDNA microarray to analyze gene expression patterns in human cancer. Nat. Genet., 14: 457-460, 1996.
46. Chee, M., Yang, R., Hubbell, E., Berno, A., Huang, X. C., Stern, D., Winkler, J., Lockhart, D. J., Morris, M. S., and Fodor, S. P. Accessing genetic information with high-density DNA arrays. Science (Washington DC), 274: 610-614, 1996.
47. Velculescu, V. E., Zhang, L., Vogelstein, B., and Kinzler, K. W. Serial analysis of gene expression. Science (Washington DC), 270: 484-487, 1995.
48. Zhang, L., Zhou, W., Velculescu, V. E., Kern, S. E., Hruban, R. H., Hamilton, S. R., Vogelstein, B., and Kinzler, K. W. Gene expression profiles in normal and cancer cells. Science (Washington DC), 276: 1268-1272, 1997.
49. Hibi, K., Liu, Q., Beaudry, G. A., Madden, S. L., Westra, W. H., Wehage, S. L., Yang, S. C., Heitmiller, R. F., Bertelsen, A. H., Sidransky, D., and Jen, J. Serial analysis of gene expression in non-small cell lung cancer. Cancer Res., 58: 5690-5694, 1998.
50. Pasqualini, R., and Ruoslahti, E. Organ targeting in vivo using phage display peptide libraries. Nature (Lond.), 380: 364-366, 1996.
51. Pasqualini, R., Koivunen, E., and Ruoslahti, E. αv integrins as receptors for tumor targeting by circulating ligands. Nat. Biotechnol., 15: 542-546, 1997.
52. Arap, W., Pasqualini, R., and Ruoslahti, E. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science (Washington DC), 279: 377-380, 1998.